Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy - Scorecard - MDSpire

Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy

  • By

  • Alexander Rau

  • Nils Schröter

  • Michel Rijntjes

  • Fabian Bamberg

  • Wolfgang H. Jost

  • Maxim Zaitsev

  • Cornelius Weiller

  • Stephan Rau

  • Horst Urbach

  • Marco Reisert

  • Maximilian F. Russe

  • May 1, 2023

  • 0 min

Share

Clinical Scorecard: Utilizing Deep Learning for Accurate Segmentation of the Putamen in Multiple System Atrophy

At a Glance

CategoryDetail
ConditionMultiple System Atrophy (MSA), an atypical Parkinson syndrome
Key MechanismsAlpha-synucleinopathy with glial cytoplasmic inclusions causing regional brain atrophy
Target PopulationPatients with clinically established or probable MSA or Parkinson's Disease (PD), and healthy controls
Care SettingNeurology and neuroimaging centers performing MRI for differential diagnosis of neurodegenerative Parkinson syndromes

Key Highlights

  • MSA is difficult to clinically differentiate from PD; MRI-based segmentation aids in diagnosis.
  • Deep learning approaches, especially Deep Neural Patchworks (DNP), improve segmentation accuracy of atrophic brain structures like the putamen.
  • DNP overcomes hardware limitations by hierarchical patch-based 3D networks, preserving global context in high-resolution images.

Guideline-Based Recommendations

Diagnosis

  • Use MRI with 3D T1-weighted MPRAGE sequences for imaging the putamen in suspected MSA and PD.
  • Employ manual segmentation by experienced neuroradiologists as ground truth for validating automated methods.
  • Consider deep learning-based segmentation (e.g., Deep Neural Patchworks) for improved accuracy over standard atlas or Freesurfer methods.

Management

  • Integrate volumetric parameters derived from accurate putamen segmentation into diagnostic workflows for atypical Parkinson syndromes.

Monitoring & Follow-up

  • Use MRI-based volumetry and segmentation to monitor disease progression and differentiate MSA from PD.

Risks

  • Be aware of potential bias in sequence parameter extraction due to inaccurate segmentation with standard atlas-based methods in atrophic brains.

Patient & Prescribing Data

Patients with clinically established or probable MSA or PD undergoing MRI evaluation

Accurate segmentation of the putamen using deep learning may enhance diagnostic precision and influence treatment decisions in atypical Parkinson syndromes.

Clinical Best Practices

  • Validate clinical diagnoses with expert neurologists using current diagnostic criteria and comprehensive medical records.
  • Use age- and sex-matched healthy controls without neurological deficits for comparison in imaging studies.
  • Apply deep learning segmentation frameworks like Deep Neural Patchworks to balance global context and hardware limitations in high-resolution MRI.
  • Combine multiple MRI sequences (T1w, FLAIR, SWI) for manual segmentation to serve as ground truth.
  • Employ automated segmentation tools (Freesurfer, Fastsurfer) with caution in cases of pronounced regional atrophy.

References

Original Source(s)

Related Content